Across the pond, a British study conducted by Professor Sir John Burn of Newcastle University and Professor Tim Bishop with Leeds University has promising news for those at risk for bowel cancer. According to The Telegraph on Friday, Oct. 28, Prof. Burn said aspirin use now could “stop about 10,000 cancers over 30 years.”
The individuals most likely to benefit from the aspirin use in this study are the approximate 60,000 in the country who suffer from Lynch Syndrome, which can result in bowel cancer. For every 1,000 people in Britain, only one person per 1,000 is likely to get Lynch Syndrome, but bowel cancer probability is much higher once they do, with one out of every 30 Lynch Syndrome suffers getting the cancer eventually.
In fact, bowel cancer ranks as the third most common cancer in the country, claiming as many as 16,000 lives annually due to the 40,000 cases seen each year. According to the study results, taking one 300-mg pill aspirin daily for two years reduced risk of bowel cancer by as much as 67 percent. Participants in the study, over 800 middle-aged people, were still bowel cancer free five years after the study, despite having Lynch Syndrome.
Frequent aspirin use, especially the uncoated variety, can lead to the development of stomach ulcers and internal bleeding, so you should consult your physician before adding any medicine to your daily routine. The Mayo Clinic provides more information regarding daily aspirin therapy for a variety of conditions.